Concepedia

R.Y. Chandrasekaran

RC

4

Publications

192

Citations

4

H-Index

1992

Active since

Affiliations

Pfizer (United States)(Current)

R.Y. Chandrasekaran is an author at Pfizer (United States) specializing in medicine, drug resistance, and drug discovery.

Top concepts

MedicineAntibioticsMicrobiologyPharmacologyDrug DiscoveryDrug ResistanceAntimicrobial ResistanceHealthChemistryBiochemistry

Publications per year

1992–2011

4

Publications

4

Discovery of Two Clinical Histamine H <sub>3</sub> Receptor Antagonists: <i>trans</i> - <i>N</i> -Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and <i>trans</i> -3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]- <i>N</i> -(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)

Travis T. Wager, Betty Pettersen, Anne W. Schmidt et al. · Journal of Medicinal Chemistry · 2011 · 107 citations · Full text

Synthesis of tetrahydropteridine C6-stereoisomers, including N5-formyl-(6S)-tetrahydrofolic acid

Steven Bailey, R.Y. Chandrasekaran, June E. Ayling · The Journal of Organic Chemistry · 1992 · 47 citations

Molecular Sciences, Bioorganic Chemistry, Chemical Measurement +13

Cyclic homopentapeptides 1. Analogs of tuberactinomycins and capreomycin with activity against vancomycin-resistant enterococci and Pasteurella

John P. Dirlam, ANNETTE M. BELTON, N. C. BIRSNER et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 22 citations

Antimicrobial Susceptibility, Health Sciences, Antibiotics +11

Cyclic homopentapeptides 3. Synthetic modifications to the capreomycins and tuberactinomycins: Compounds with activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci

R. G. II LINDE, N. C. BIRSNER, R.Y. Chandrasekaran et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 16 citations

Medicinal Chemistry, Synthetic Modifications, Methicillin-resistant Staphylococcus Aureus +12

Rows per page

1–4 of 4